Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05881252 · ClinicalTrials.gov registry record
Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 1,003
- Enrollment target
NCT05881252: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT05881252 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,003 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05881252 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 1,003 participants
- Enrollment target
Study Summary
The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is \>= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of \>= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (\>= 180 SBP).
Primary Outcome
The primary outcome is a composite outcome, and will be reported as number of patients who have Congestive Heart Failure/Pulmonary Edema, hemorrhagic or ischemic Stroke, Acute Kidney Injury (creatinine \> 1.5mg/dL), and/or Myocardial Ischemia.
Interventions
- PROCEDURE Clinical blood pressure threshold of SBP >= 160 mmHg for acute treatment of hypertension
- PROCEDURE Clinical blood pressure threshold of SBP >= 180 mmHg for acute treatment of hypertension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,003 participants |
| Start Date | 2023-05-11 |
| Est. Completion | 2024-04-04 |
What the finished NCT05881252 record still lists
NCT05881252 is an observational study that tracks outcomes without assigning an intervention. Its 1,003 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Clinical blood pressure threshold of SBP >= 160 mmHg for acute treatment of hypertension is the first listed.
NCT05881252 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05881252 about?
NCT05881252 is a clinical study titled "Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension". The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for a...
What is the current status of trial NCT05881252?
This trial is currently completed. The enrollment target is 1,003 participants. The study started on 2023-05-11. Estimated completion is 2024-04-04.
What interventions are being tested in trial NCT05881252?
The interventions under investigation include: Clinical blood pressure threshold of SBP >= 160 mmHg for acute treatment of hypertension (PROCEDURE), Clinical blood pressure threshold of SBP >= 180 mmHg for acute treatment of hypertension (PROCEDURE).
Who is sponsoring clinical trial NCT05881252?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI